{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:31:18Z","timestamp":1772253078027,"version":"3.50.1"},"reference-count":82,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI174875"],"award-info":[{"award-number":["AI174875"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["AI174276"],"award-info":[{"award-number":["AI174276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["DP2DA040254"],"award-info":[{"award-number":["DP2DA040254"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["1DP1DA060607"],"award-info":[{"award-number":["1DP1DA060607"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Quantifying viral growth rates is key to understanding evolutionary dynamics and the potential for mutants to escape antiviral drugs. Defining evolutionary escape paths and their impact on viral fitness allows for the development of drugs that are resistant to escape. In the case of HIV, combination antiretroviral therapy can successfully prevent or treat infection, but it relies on strict adherence to prevent escape. Here, we present a method termed QuickFit that enables the quantification of viral fitness by employing large numbers of parallel viral cultures to measure growth rates accurately. QuickFit consistently recapitulated HIV growth measurements obtained by traditional approaches, but with significantly higher throughput and lower rates of error. This method represents a promising tool for rapid and consistent evaluation of viral fitness.<\/jats:p>","DOI":"10.3390\/v16081320","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T05:19:36Z","timestamp":1724044776000},"page":"1320","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-7882","authenticated-orcid":false,"given":"Nicolas M. S.","family":"Galvez","sequence":"first","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maegan L.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-308X","authenticated-orcid":false,"given":"Allen Z.","family":"Lin","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-2559","authenticated-orcid":false,"given":"Evan C.","family":"Lam","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9749-9431","authenticated-orcid":false,"given":"Abigail M.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1767-3944","authenticated-orcid":false,"given":"Alejandro B.","family":"Balazs","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coviro.2012.07.007","article-title":"Viral Fitness: Definitions, Measurement, and Current Insights","volume":"2","author":"Wargo","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1051\/vetres\/2010010","article-title":"Mechanisms of Viral Emergence","volume":"41","author":"Domingo","year":"2010","journal-title":"Vet. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sanju\u00e1n, R., and Domingo-Calap, P. (2021). Genetic Diversity and Evolution of Viral Populations. Encyclopedia of Virology, Elsevier.","DOI":"10.1016\/B978-0-12-809633-8.20958-8"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/01.aids.0000180098.58017.48","article-title":"Plasma Virion Reverse Transcriptase Activity and Heat Dissociation-Boosted P24 Assay for HIV Load in Burkina Faso, West Africa","volume":"19","author":"Lombart","year":"2005","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.77.22.12105-12112.2003","article-title":"Relationship between In Vitro Human Immunodeficiency Virus Type 1 Replication Rate and Virus Load in Plasma","volume":"77","author":"Campbell","year":"2003","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-0934(02)00230-6","article-title":"Comparison of TaqManTM Real-Time PCR and P24 Elisa for Quantification of In Vitro HIV-1 Replication","volume":"107","author":"Klein","year":"2003","journal-title":"J. Virol. Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV Infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_8","unstructured":"Eggleton, J.S., and Nagalli, S. (2024). Highly Active Antiretroviral Therapy (HAART). StatPearls, StatPearls Publishing."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1007\/s10461-020-02855-9","article-title":"Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming","volume":"24","author":"Hillis","year":"2020","journal-title":"AIDS Behav."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral Pre-Exposure Prophylaxis (PrEP) to Prevent HIV: A Systematic Review and Meta-Analysis of Clinical Effectiveness, Safety, Adherence and Risk Compensation in All Populations","volume":"12","author":"Murchu","year":"2022","journal-title":"BMJ Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society\u2013USA Panel","volume":"316","author":"Saag","year":"2016","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ch\u00e1vez-Hern\u00e1ndez, A.L., Ju\u00e1rez-Mercado, K.E., Sald\u00edvar-Gonz\u00e1lez, F.I., and Medina-Franco, J.L. (2021). Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products. Biomolecules, 11.","DOI":"10.20944\/preprints202111.0125.v1"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fofana, D.B., Diarra, H., Guindo, I., Savadogo, M.K., d\u2019Almeida, M., Diallo, F.I., Bald\u00e9, A., Souli\u00e9, C., Kone, A., and Marcelin, A.-G. (2023). Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children. Viruses, 15.","DOI":"10.3390\/v15020546"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2352-3018(20)30232-0","article-title":"The Case for an HIV Cure and How to Get There","volume":"8","author":"Dybul","year":"2021","journal-title":"Lancet HIV"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAI.0b013e31817ecb31","article-title":"In Vitro Characterization of Multidrug-Resistant HIV-1 Isolates from a Recently Infected Patient Associated with Dual Tropism and Rapid Disease Progression","volume":"48","author":"Mohri","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr. 1999"},{"key":"ref_16","first-page":"136","article-title":"The Impact of the M184V Resistance Mutation on Treatment Outcomes in Patients with HIV Infection: A Systematic Review and Meta-Analysis","volume":"26","author":"Kandeel","year":"2023","journal-title":"AIDS Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1089\/aid.2020.0109","article-title":"Short Communication: HIV-DRLink: A Tool for Reporting Linked HIV-1 Drug Resistance Mutations in Large Single-Genome Data Sets Using the Stanford HIV Database","volume":"36","author":"Shao","year":"2020","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"vex003","DOI":"10.1093\/ve\/vex003","article-title":"In Vivo Mutation Rates and the Landscape of Fitness Costs of HIV-1","volume":"3","author":"Zanini","year":"2017","journal-title":"Virus Evol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"K\u00fchnert, D., Kouyos, R., Shirreff, G., Pe\u010derska, J., Scherrer, A.U., B\u00f6ni, J., Yerly, S., Klimkait, T., Aubert, V., and G\u00fcnthard, H.F. (2018). Quantifying the Fitness Cost of HIV-1 Drug Resistance Mutations through Phylodynamics. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006895"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.02712-06","article-title":"The Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions","volume":"81","author":"Cong","year":"2007","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhou, T., Zhang, Y., Luo, S., Chen, H., Chen, D., Li, C., and Li, W. (2022). The Reservoir of Latent HIV. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.945956"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12977-018-0404-7","article-title":"Measuring Replication Competent HIV-1: Advances and Challenges in Defining the Latent Reservoir","volume":"15","author":"Wang","year":"2018","journal-title":"Retrovirology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Vetter, B.N., Orlowski, V., Niederhauser, C., Walter, L., and Sch\u00fcpbach, J. (2015). Impact of Naturally Occurring Amino Acid Variations on the Detection of HIV-1 P24 in Diagnostic Antigen Tests. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1174-7"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Vetter, B.N., Orlowski, V., Fransen, K., Niederhauser, C., Aubert, V., Brandenberger, M., Ciardo, D., Dollenmaier, G., Klimkait, T., and Regenass, S. (2014). Generation of a Recombinant Gag Virus-like-Particle Panel for the Evaluation of P24 Antigen Detection by Diagnostic HIV Tests. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111552"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12985-023-02242-5","article-title":"In-House ELISA Protocols for Capsid P24 Detection of Diverse HIV Isolates","volume":"20","author":"Molina","year":"2023","journal-title":"Virol. J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fan, P., Li, X., Su, W., Kong, W., Kong, X., Wang, Z., Wang, Y., Jiang, C., and Gao, F. (2015). Enhanced Sensitivity for Detection of HIV-1 P24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125701"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Levinger, C., Howard, J.N., Cheng, J., Tang, P., Joshi, A., Catalfamo, M., and Bosque, A. (2021). An Ultrasensitive Planar Array P24 Gag ELISA to Detect HIV-1 in Diverse Biological Matrixes. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-03072-7"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T Cell Reactivity to the SARS-CoV-2 Omicron Variant Is Preserved in Most but Not All Individuals","volume":"185","author":"Naranbhai","year":"2022","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nm.3471","article-title":"Vectored Immunoprophylaxis Protects Humanized Mice from Mucosal HIV Transmission","volume":"20","author":"Balazs","year":"2014","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of Gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/JVI.00709-09","article-title":"Evidence That Ecotropic Murine Leukemia Virus Contamination in TZM-Bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1","volume":"83","author":"Platt","year":"2009","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","article-title":"Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/s41467-021-22654-7","article-title":"Modification of N-Terminal \u03b1-Amine of Proteins via Biomimetic Ortho-Quinone-Mediated Oxidation","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fassy, J., Lacoux, C., Leroy, S., Noussair, L., Hubac, S., Degoutte, A., Vassaux, G., Leclercq, V., Rouqui\u00e9, D., and Marquette, C.-H. (2021). Versatile and Flexible Microfluidic qPCR Test for High-Throughput SARS-CoV-2 and Cellular Response Detection in Nasopharyngeal Swab Samples. PloS ONE, 16.","DOI":"10.1371\/journal.pone.0243333"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sentmanat, M., Kouranova, E., and Cui, X. (2020). One-Step RNA Extraction for RT-qPCR Detection of 2019-nCoV 2020. bioRxiv, bioRxiv:2020.04.02.022384.","DOI":"10.1101\/2020.04.02.022384"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ladha, A., Joung, J., Abudayyeh, O.O., Gootenberg, J.S., and Zhang, F. (2020). A 5-Min RNA Preparation Method for COVID-19 Detection with RT-qPCR 2020. medRxiv, medRxiv:2020.05.07.20055947.","DOI":"10.1101\/2020.05.07.20055947"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/psp4.12500","article-title":"Efficient Pharmacokinetic Modeling Workflow with the MonolixSuite: A Case Study of Remifentanil","volume":"9","author":"Traynard","year":"2020","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10928-010-9175-z","article-title":"The Use of the SAEM Algorithm in MONOLIX Software for Estimation of Population Pharmacokinetic-Pharmacodynamic-Viral Dynamics Parameters of Maraviroc in Asymptomatic HIV Subjects","volume":"38","author":"Chan","year":"2011","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/JVI.06157-11","article-title":"Generation of Transmitted\/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages","volume":"86","author":"Ochsenbauer","year":"2012","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"eabn9662","DOI":"10.1126\/scitranslmed.abn9662","article-title":"Antibody-Mediated Prevention of Vaginal HIV Transmission Is Dictated by IgG Subclass in Humanized Mice","volume":"14","author":"Brady","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1128\/AAC.47.11.3377-3383.2003","article-title":"Molecular Impact of the M184V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase","volume":"47","author":"Diallo","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/jvi.66.12.7128-7135.1992","article-title":"Novel Mutation in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene That Encodes Cross-Resistance to 2\u2019,3\u2019-Dideoxyinosine and 2\u2019,3\u2019-Dideoxycytidine","volume":"66","author":"Gu","year":"1992","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced Replication of 3TC-Resistant HIV-1 Variants in Primary Cells Due to a Processivity Defect of the Reverse Transcriptase Enzyme","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e02557-19","DOI":"10.1128\/AAC.02557-19","article-title":"Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V","volume":"64","author":"Margot","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109167","DOI":"10.1016\/j.celrep.2021.109167","article-title":"Mining HIV Controllers for Broad and Functional Antibodies to Recognize and Eliminate HIV-Infected Cells","volume":"35","author":"Rossignol","year":"2021","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dingens, A.S., Acharya, P., Haddox, H.K., Rawi, R., Xu, K., Chuang, G.-Y., Wei, H., Zhang, B., Mascola, J.R., and Carragher, B. (2018). Complete Functional Mapping of Infection- and Vaccine-Elicited Antibodies against the Fusion Peptide of HIV. PLoS Pathog., 14.","DOI":"10.1101\/307587"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1128\/JVI.00127-10","article-title":"Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 Infection","volume":"84","author":"Ribeiro","year":"2010","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/CMR.00017-07","article-title":"Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness","volume":"20","author":"Dykes","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_50","first-page":"224","article-title":"Fitness of Drug Resistant HIV-1: Methodology and Clinical Implications","volume":"5","author":"Arts","year":"2002","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jviromet.2005.10.016","article-title":"A Novel Small Reporter Gene and HIV-1 Fitness Assay","volume":"133","author":"Ali","year":"2006","journal-title":"J. Virol. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12981-015-0066-7","article-title":"Defining the Fitness of HIV-1 Isolates with Dual\/Mixed Co-Receptor Usage","volume":"12","author":"Nankya","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/JVI.74.19.9222-9233.2000","article-title":"A Dual Infection\/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression","volume":"74","author":"Ball","year":"2000","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12981-017-0144-0","article-title":"Impaired Human Immunodeficiency Virus Type 1 Replicative Fitness in Atypical Viremic Non-Progressor Individuals","volume":"14","author":"Weber","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tebit, D.M., Nickel, G., Gibson, R., Rodriguez, M., Hathaway, N.J., Bain, K., Reyes-Rodriguez, A.L., Ondoa, P., Heeney, J.L., and Li, Y. (2024). Replicative Fitness and Pathogenicity of Primate Lentiviruses in Lymphoid Tissue, Primary Human and Chimpanzee Cells: Relation to Possible Jumps to Humans. EBioMedicine, 100.","DOI":"10.1016\/j.ebiom.2023.104965"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rindler, A.E., Kuster, H., Neumann, K., Leemann, C., Braun, D.L., Metzner, K.J., and G\u00fcnthard, H.F. (2021). A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells. Viruses, 13.","DOI":"10.3390\/v13030404"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients","volume":"48","author":"Metzner","year":"2009","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1099\/vir.0.19123-0","article-title":"A Novel TaqMan Real-Time PCR Assay to Estimate Ex Vivo Human Immunodeficiency Virus Type 1 Fitness in the Era of Multi-Target (Pol and Env) Antiretroviral Therapy","volume":"84","author":"Weber","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1373\/jalm.2017.023952","article-title":"Variability in Microplate Surface Properties and Its Impact on ELISA","volume":"2","author":"Lilyanna","year":"2018","journal-title":"J. Appl. Lab. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"113160","DOI":"10.1016\/j.jim.2021.113160","article-title":"Qualification of ELISA and Neutralization Methodologies to Measure SARS-CoV-2 Humoral Immunity Using Human Clinical Samples","volume":"499","author":"Larsen","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jim.2008.04.001","article-title":"The ELISA Standard Save: Calculation of Sample Concentrations in Assays with a Failed Standard Curve","volume":"336","author":"Natarajan","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kibirige, C.N., Manak, M., King, D., Abel, B., Hack, H., Wooding, D., Liu, Y., Fernandez, N., Dalel, J., and Kaye, S. (2022). Development of a Sensitive, Quantitative Assay with Broad Subtype Specificity for Detection of Total HIV-1 Nucleic Acids in Plasma and PBMC. Sci. Rep., 12.","DOI":"10.1038\/s41598-021-03016-1"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Nyirenda, J.T., Henrion, M.Y.R., Nyasulu, V., Msakwiza, M., Nedi, W., Thole, H., Phulusa, J., Toto, N., Jere, K.C., and Winter, A. (2023). Examination of ELISA against PCR for Assessing Treatment Efficacy against Cryptosporidium in a Clinical Trial Context. PloS ONE, 18.","DOI":"10.1371\/journal.pone.0289929"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exppara.2018.01.011","article-title":"Comparison of ELISA, Nested PCR and Sequencing and a Novel qPCR for Detection of Giardia Isolates from Jordan","volume":"185","author":"Hijjawi","year":"2018","journal-title":"Exp. Parasitol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1128\/JCM.05669-11","article-title":"A New Real-Time Quantitative PCR for Diagnosis and Monitoring of HIV-1 Group O Infection","volume":"50","author":"Gueudin","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Marino-Merlo, F., Stefanizzi, V., Ragno, A., Piredda, L., Grelli, S., Macchi, B., and Mastino, A. (2022). Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay. Life, 12.","DOI":"10.3390\/life12081130"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1137\/S0036144598335107","article-title":"Mathematical Analysis of HIV-1 Dynamics In Vivo","volume":"41","author":"Perelson","year":"1999","journal-title":"SIAM Rev."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Iwami, S., Sato, K., De Boer, R.J., Aihara, K., Miura, T., and Koyanagi, Y. (2012). Identifying Viral Parameters from In Vitro Cell Cultures. Front. Microbiol., 3.","DOI":"10.3389\/fmicb.2012.00319"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Khan, S.U., Ullah, S., Li, S., Mostafa, A.M., Bilal Riaz, M., AlQahtani, N.F., and Teklu, S.W. (2024). A Novel Simulation-Based Analysis of a Stochastic HIV Model with the Time Delay Using High Order Spectral Collocation Technique. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-57073-3"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"D\u2019Orso, I., and Forst, C.V. (2023). Mathematical Models of HIV-1 Dynamics, Transcription, and Latency. Viruses, 15.","DOI":"10.3390\/v15102119"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Li, H., Kuga, K., and Ito, K. (2023). Visual Prediction and Parameter Optimization of Viral Dynamics in the Mucus Milieu of the Upper Airway Based on CFPD-HCD Analysis. Comput. Methods Programs Biomed., 238.","DOI":"10.1016\/j.cmpb.2023.107622"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Thingstad, T.F., Pree, B., Giske, J., and V\u00e5ge, S. (2015). What Difference Does It Make If Viruses Are Strain-, Rather than Species-Specific?. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00320"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.1400909111","article-title":"A Theoretical Analysis of How Strain-Specific Viruses Can Control Microbial Species Diversity","volume":"111","author":"Thingstad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"veaa089","DOI":"10.1093\/ve\/veaa089","article-title":"Simulating within Host Human Immunodeficiency Virus 1 Genome Evolution in the Persistent Reservoir","volume":"6","author":"Jones","year":"2020","journal-title":"Virus Evol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/JVI.74.14.6262-6268.2000","article-title":"Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: The Relative Roles of Drift and Selection","volume":"74","author":"Frost","year":"2000","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11309","DOI":"10.1128\/JVI.05578-11","article-title":"Interaction of Reverse Transcriptase (RT) Mutations Conferring Resistance to Lamivudine and Etravirine: Effects on Fitness and RT Activity of Human Immunodeficiency Virus Type 1","volume":"85","author":"Hu","year":"2011","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1128\/JVI.79.15.9572-9578.2005","article-title":"Comparative Selection of the K65R and M184V\/I Mutations in Human Immunodeficiency Virus Type 1-Infected Patients Enrolled in a Trial of First-Line Triple-Nucleoside Analog Therapy (Tonus IMEA 021)","volume":"79","author":"Delaunay","year":"2005","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/171.6.1411","article-title":"Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)","volume":"171","author":"Schuurman","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7150\/thno.5392","article-title":"The Puzzling Role of CXCR4 in Human Immunodeficiency Virus Infection","volume":"3","author":"Vicenzi","year":"2013","journal-title":"Theranostics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0179823","DOI":"10.1128\/jvi.01798-23","article-title":"A Novel High-Throughput Microwell Outgrowth Assay for HIV-Infected Cells","volume":"98","author":"Fenton","year":"2024","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Salasc, F., Gludish, D.W., Jarvis, I., Boliar, S., Wills, M.R., Russell, D.G., Lever, A.M.L., and Mok, H.-P. (2019). A Novel, Sensitive Dual-Indicator Cell Line for Detection and Quantification of Inducible, Replication-Competent Latent HIV-1 from Reservoir Cells. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-55596-8"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1074\/jbc.M710149200","article-title":"Reduced dNTP Binding Affinity of 3TC-Resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage","volume":"283","author":"Jamburuthugoda","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1320\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:38:50Z","timestamp":1760110730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":82,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["v16081320"],"URL":"https:\/\/doi.org\/10.3390\/v16081320","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.08.602587","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}